FORMULATION AND DEVELOPMENT OF LORNOXICAM BILAYER TABLETS

D R Nagesh, Rakesh Kumar Jat, Syed Mansoor Ahmed

Abstract


Point of present examination work was attempted to figure bilayer tablets of lornoxicam through its joining of oral measurements frame that can release lornoxicam promptly in addition maintained sustained release of lornoxicam for 24 hrs to improve oral bioavailability of lornoxicam. Primary target of this work was plan of bilayer tablets utilizing superdisintegrant Kyron 314 for smart discharge layer Polyox 303 for supporting discharge layer made out of two unique classes of medications by utilizing straight forward simple to-scale-up definition system. The in vitro dissolution study of the prepared bilayer tablets showed a controlled release of active drugs over a period of 24 hours

Key Words:  Bilayer Tablets, lornoxicam, Superdisintegrant, sustained release

 


References


Jha MK, Rahman MH and Rahman MM, “Biphasic oral solid drug delivery system: a review.” Int. J. Pharm Sci and Res, 2, 2011, 1108- 1115.

Saravanan V., Revathi R., Meera N. Method development and validation for the simultaneous estimation of lycopene and ubidecarenone by RP-HPLC in combined pharmaceutical dosage form. Journal of Drug Delivery and Therapeutics, 2016; 6(5): 46-51.

Abebe A, Akseli I, Sprockel O, Kottala N, and Cuitino AM, “Review of Bilayer Tablet Technology.” International. J. Pharmaceutics, 461, 2014, 549- 558.

Dagariya RK, Jat RK, Method development and validation of Irbesartan chlorthalidone and Cilnidipine in their combined tablet dosage form by high performance liquid chromatography, Journal of Drug Delivery and Therapeutics. 2017; 7(4):88-96 DOI: http://dx.doi.org/10.22270/jddt.v7i4.1471

Kumar AP, Pramodaganta, Bhoopathi SG and, Kulkarni SV, “Current Innovation in Layered Tablet Technology: Review.” Asian. J. Res pharm. sci. 3, 2013 189-194.

Garg A, Gupta MM, Taste masking and formulation development & evaluation of mouth dissolving tablets of levocetrizine dihydrochloride, Journal of Drug Delivery & Therapeutics; 2013; 3(3):123-130

Cutolo M, Straub RH, Buttgereit F. Circadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedside. Ann Rheum Dis 2008; 67 (7):905-908.

Patil S, Gupta V. Design and in vitro evaluation of multiparticulate system for the chronomodulated delivery of lornoxicam. Journal of Drug Delivery and Therapeutics, 2015; 5(3):62-71. doi:10.22270/jddt.v5i3.1148

Merck & Co. Inc. The Merck index. 13th ed. Whitehouse Station: Merck & Co. Inc.; 2001.

Momin S, Khan S, Ghadage DM, Yadav AV, Wagh A, Formulation and evaluation of bilayer tablets of propranolol hydrochloride, Journal of Drug Delivery and Therapeutics. 2017; 7(2)50-57. DOI: http://dx.doi.org/10.22270/jddt.v7i2.1399

Debajyoti Ray, Amresh K Prusty. Designing and invitro studies of gastric floating Tabletss of Tramadol hydrochloride, Int J Appl Pharm. 2010; 2(4):12-16.

Patel K, Vyas J, Upadhyay U. Formulation and evaluation of sustained release matrix tablets of nateglinide. Journal of Drug Delivery and Therapeutics, 2015; 5(5):19-25. doi:10.22270/jddt.v5i5.1130

Agrawal R, Pharmaceutical processing- a review on wet granulation technology. IJPFR. 2011; (1):65-83


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

footer_848
ISSN: 2250-1177  This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.